Morphological changes induced by HIV-related lipodystrophy profoundly affect body image and influence health-related quality of life. Measurements of health-related quality of life in patients ...

£35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts. Lipodystrophy is a side-effect of some anti-HIV drugs. These are mainly ...

KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...

The topic of glucose metabolism and insulin resistance received a great deal of attention at the meeting with several complementary -- and some not so complimentary -- presentations. As background ...

The findings reported by the researchers answer some of the questions as to why patients receiving successful treatment for HIV end up with abnormal fat loss and deposits – a problem call ...

Novelion Therapeutics’ Myalepta (metreleptin) developed for the ultra-rare condition lipodystrophy has been approved by the European Commission, giving patients the first treatment to improve ...

Resubmission addresses questions raised in January 2024 Complete Response LetterF8 formulation intended to replace EGRIFTA SV® with simplified ...

Theratechnologies (NASDAQ:THTX) has resubmitted its supplemental Biologics License Application for a simplified dosing formulation of its drug tesamorelin for the reduction of excess abdominal fat in ...

the only medication approved in the U.S. for the reduction of excess abdominal fat in adults with HIV who have lipodystrophy. Theratechnologies has filed the resubmission to address concerns raised in ...